ReviewClinical obstetrics and gynecology2012
The oviduct and ovarian cancer: causality, clinical implications, and "targeted prevention".
Review in Clinical obstetrics and gynecology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
45 citing papers in PubMed, 1 synthesis or guideline pooled it, 71 citations in OpenAlex.
- Systematic review and meta-analysis on the impact of the levonorgestrel-releasing intrauterine system in reducing risk of ovarian cancer.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2022Pooled it
- Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2014Trial
- Bacterial Infections Role in Gynecological Cancers Development: Narrative Review.Cancer reports (Hoboken, N.J.) · 2026Review
- Serous Tubal Intraepithelial Carcinoma (STIC): A Review of the Literature on the Incidence at the Time of Prophylactic Surgery.Diagnostics (Basel, Switzerland) · 2024Review
- HPV-YAP1 oncogenic alliance drives malignant transformation of fallopian tube epithelial cells.EMBO reports · 2024Article
- Prognostic significance and risk factors for pelvic and para-aortic lymph node metastasis in type I and type II ovarian cancer: a large population-based database analysis.Journal of ovarian research · 2023Article
- Significance of Pelvic Fluid Observed during Ovarian Cancer Screening with Transvaginal Sonogram.Diagnostics (Basel, Switzerland) · 2022Article
- A bespoke target selection tool to guide biomarker discovery in tubo-ovarian cancer.Computational and structural biotechnology journal · 2022Article
- Modeling High-Grade Serous Ovarian Carcinoma Using a Combination ofCancer research · 2021Article
- Methylomic Landscapes of Ovarian Cancer Precursor Lesions.Clinical cancer research : an official journal of the American Association for Cancer Research · 2020Article
- Liquid biopsy in ovarian cancer: Catching the silent killer before it strikes.World journal of clinical oncology · 2020Review
- FIGO staging in ovarian carcinoma and histological subtypes.Journal of gynecologic oncology · 2020Article
- Disease-Specific Survival of Type I and Type II Epithelial Ovarian Cancers-Stage Challenges Categorical Assignments of Indolence & Aggressiveness.Diagnostics (Basel, Switzerland) · 2020Article
- Loss of tubal ciliated cells as a risk for "ovarian" or pelvic serous carcinoma.American journal of cancer research · 2020Article
- Preclinical Models of Ovarian Cancer: Pathogenesis, Problems, and Implications for Prevention.Clinical obstetrics and gynecology · 2017Review
- Microbial infection, inflammation and epithelial ovarian cancer.Oncology letters · 2017Article
- Ultrasound Monitoring of Extant Adnexal Masses in the Era of Type 1 and Type 2 Ovarian Cancers: Lessons Learned From Ovarian Cancer Screening Trials.Diagnostics (Basel, Switzerland) · 2017Review
- A Resident's Perspective of Ovarian Cancer.Diagnostics (Basel, Switzerland) · 2017Article
- Ovarian Cancer Incidence Corrected for Oophorectomy.Diagnostics (Basel, Switzerland) · 2017Article
- Complications from Surgeries Related to Ovarian Cancer Screening.Diagnostics (Basel, Switzerland) · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 2 countries.
Funding
Abstract
A novel origin for pelvic serous cancer (ovarian cancer) has been proposed in the distal oviduct. This has important implications, including both early detection in high-risk women and wisdom of relying on serological tests to detect a disease that begins so close to the peritoneal surfaces. With the recent discovery of premalignant disturbances in gene function in the tubal mucosa, the concept of targeted prevention is emerging whereby the interruption of a portion of the carcinogenic pathway will prevent cancer. This alternative to detect early malignancy is a new paradigm in the quest to prevent this deadly disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.